News | September 21, 2023
Venus Remedies gets marketing approval for gemcitabine and docetaxel in Serbia
With this, the company has secured 511 marketing approvals for its oncology products across 66 countries
With this, the company has secured 511 marketing approvals for its oncology products across 66 countries
OncoVeryx-F, a proprietary test developed by PredOmix, is set to transform early-stage cancer detection
Company intends to increase sales in the UK to approximately 2 million Euros by focusing on seven molecules which are already registered in the country
According to GlobalData’s analyst consensus forecast, OTX-2002 is projected to have the highest revenue by 2028, with sales of $1.6 billion during that year
Results showed a statistically significant and clinically meaningful improvement in investigator-assessed progression-free survival
Specialized cancer care will be offered to cancer patients making it accessible and affordable. We have adopted a patient-centric approach.
DEP® ADCs exploit the unique potential of Starpharma's DEP® technology to provide enhanced characteristics to ADCs i
GlobalData’s ‘Pharmaceutical Intelligence Center’ observes that India is still in the nascent stage of developing these potential therapies as currently only four cell/gene therapy molecules are being developed in the country.
Capnomed successfully introduced the medical device Capnopen, the gold standard of laparoscopic nebulizers.
Researchers found that the drug combination led to a sustained and tenfold increase in the production of CD8 T cells and natural killer cells
Subscribe To Our Newsletter & Stay Updated
